Anti-Human CA125/MUC16 Reference Antibody (Oregovomab, RUO)

Description: Oregovomab (BS10376) is a research-grade recombinant antibody targeting Mucin-16. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Mouse
Isotype: IgG1-kappa
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1.36mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: Mucin-16,CA-125,OvariancarcinomaantigenCA125,CA125,MUC-16,Ovariancancer-relatedtumormarkerCA125,MUC16
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: MAB-B43.13,oregovamab,CAS:213327-37-8
Background: Mucin-16 (MUC16/CA-125) is a ~1519 kDa protein. Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.
Note: For research use only. Not suitable for clinical or therapeutic use.